Mofezolac
Alternative Names: Disopain; N 22Latest Information Update: 01 Oct 2007
At a glance
- Originator Gilead Sciences
- Developer Mitsubishi Tanabe Pharma Corporation
- Class Analgesics; Antirheumatics; Isoxazoles; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Musculoskeletal disorders; Pain; Postoperative pain; Rheumatic disorders
Most Recent Events
- 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
- 04 Nov 2006 Raylo Chemicals has been acquired and merged into Gilead Sciences
- 06 Apr 2000 Yoshitomi is now called Welfide Corporation